During the past decade, Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie" are "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie" in a lesser frequency.

Most popular intervention types in "Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CHOP" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Fludarabine" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".